Work

Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2016.01.008

Authors: John J. Lepore, Eric Olson, Laura Demopoulos, Thomas Haws, Zixing Fang, April M. Barbour, Michael Fossler, Victor G. Davila-Roman, Stuart D. Russell, Robert J. Gropler

Institutions: GlaxoSmithKline (United States), Washington University in St. Louis, Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: GlaxoSmithKline

Award: G2318524400

OpenAlex ID: W2335779504

FWCI: 13.49

Cites: 31

Cited by: 167

Related to: 10